Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzeveria or an EU-approved mRNA COVID-19 vaccine AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]), has been granted approval in the European Union (EU) by the European Medicine Agency (EMA) as a third dose booster in adults.Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA
Update on the safety of COVID-19 Vaccine AstraZeneca
—
Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its rea...
LIV-24 applies ESG Tech AI technology, revolutionising industrial sector Cuts costs, increases productivity, facilitates sustainable business
—
At present,...
TAT and International Partners Urge Thai Businesses to Prepare for Imminent EU Regulations on Sustainable Tourism
—
On September 26, at the Avani+ Riversi...
International efforts to protect and empower ASEAN's women migrant workers
—
International organisations under the United Nations (UN) and the European Un...
EXPORT PROMOTION SEMINAR TO HIGHLIGHT EXCELLENCE OF EUROPEAN FOOD
—
H.E. Mr. David Daly, Ambassador of the European Union to Thai (EU) is set to host a tw...
'EU Sustainable Food & Craft Market' champions sustainable SMEs to mark Europe Day
—
To celebrate Europe Day 2022, the Delegation of the European Unio...
TH-EU: The Phuket Youth's Awareness Raising for Separate Collection
—
Today, the Prince of Songkhla University, Phuket Campus was the hub to learn and exc...
BLUE ELEPHANT GROUP'S STEPPE FAMILY MEETS AMBASSADOR OF THAILAND TO BELGIUM
—
H.E. Mr. Sek Wannamethee (2nd from left), Head of the Thai delegation to the...